ArticleThe Lancet regional health. Southeast Asia2025

Beyond immunogenicity: durability, dosing, and target populations for XBB.1.5 subunit COVID-19 boosters.

Jun Norkaew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.